Rank 23 • MedTech & Devices
Tandem Diabetes Care
Develops smart insulin pumps and automated insulin delivery systems integrated with continuous glucose monitoring.
Visit website- Signal Score
- 90.8
- Total raised
- $120M
- Stage
- Public
- Founded
- 2006
- Headquarters
- San Diego, United States
- Region
- North America
Their signal
Tandem remains a top-tier player in diabetes care, leveraging its Control-IQ technology to automate insulin dosing and maintain high customer satisfaction.
Signal Score 90.8editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in MedTech & Devices
Did we miss something?
Change, add or remove details on this company. Our desk reviews every request.
Figures are subjective research desk estimates compiled from public sources and refreshed monthly, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.